Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-27 @ 2:50 AM
Study NCT ID:
NCT01056393
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2010-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Sponsor:
Kaiser Permanente
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5460
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |